Sunday, October 9, 2016

Pyril Mal Phenyl HCl Dex HBr





Dosage Form: oral suspension
Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension

Indications and Usage for Pyril Mal Phenyl HCl Dex HBr


Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension is indicated for temporary relief of the inflammation, nasal congestion, and cough associated with the common cold, sinusitis, allergic rhinitis, and other upper respiratory conditions. Appropriate therapy should be provided for the primary disease.

Pyril Mal Phenyl HCl Dex HBr Dosage and Administration


RECOMMENDED DOSES MAY BE ADMINISTERED EVERY 8 HOURS.

Adults and children 12 years of age and older: 5-10 mL (1-2 teaspoonfuls). (2)

Children 6-12 years of age: 5 mL (1 teaspoonful). (2)

Children 2-6 years of age: 2.5 mL (1/2 teaspoonful). (2)

Under 2 years of age: Consult a physician. (2)

DOSAGE FORM AND STRENGTH


Oral suspension, pyrilamine maleate 16 mg, phenylephrine hydrochloride 5 mg, dextromethorphan hydrobromide 15 mg per 5 mL

Contraindications


Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension is contraindicated in patients with a known sensitivity to any of its components. It is also contraindicated in patients with severe hypertension or peripheral vascular insufficiency, as ischemia may result, with the risk of gangrene or thrombosis of compromised vascular beds.


Antihistamines are contraindicated for use in the treatment of lower respiratory tract conditions, including asthma.


Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension should not be used in patients receiving a monoamine oxidase (MAO) inhibitor. (See 5 WARNINGS AND PRECAUTIONS and 7 DRUG INTERACTIONS)

Warnings and Precautions


5.1 General

Antihistamines may cause drowsiness and may have additive CNS effects with alcohol or other CNS depressants such as hypnotics, sedatives, and tranquilizers.


5.2 Special Risk Patients

Use with caution in patients with diabetes, hypertension, or cardiovascular disease, hyperthyroidism, narrow angle glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction, and urinary bladder obstruction due to symptomatic prostatic hypertrophy and narrowing of the bladder neck.


Dextromethorphan should be used with caution in sedated patients, and in patients confined to the supine position.


Antihistamines may cause excitability, particularly in pediatric patients, but their combination with sympathomimetics may cause either mild stimulation or mild sedation. Administration of dextromethorphan may be accompanied by histamine release and should be used with caution in atopic children.


Antihistamines are more likely to cause dizziness, sedation, and hypotension in elderly patients and should be prescribed with caution.

Adverse Reactions


The most common side effects associated with antihistamines include drowsiness, sedation, dryness of mucous membranes, and gastrointestinal effects. Serious side effects with oral antihistamines, sympathomimetics, and antitussives have been rare.


Other reactions may include:


Dermatologic: urticaria, drug rash, photosensitivity, pruritus


Cardiovascular: hypotension, hypertension, cardiac arrhythmias, palpitations


Central Nervous System (CNS): disturbed coordination, tremor, irritability, insomnia, visual disturbances, weakness, nervousness, convulsion, headache, euphoria, and dysphoria


Genitourinary: urinary frequency, difficult urination


Gastrointestinal: epigastric discomfort, anorexia, nausea, vomiting, diarrhea, constipation


Respiratory: tightness of chest and wheezing, shortness of breath


Hematologic: hemolytic anemia, thrombocytopenia, agranulocytosis


To report SUSPECTED ADVERSE REACTIONS, contact FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Drug Interactions


MAO inhibitors may prolong and intensify the anticholinergic effects of antihistamines and the overall effects of sympathomimetic agents. Patients may develop hyperpyrexia, hypotension, nausea, myoclonic leg jerks, and coma following coadministration of MAO inhibitors and dextromethorphan. Therefore, concomitant administration of Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension and MAO inhibitors should be avoided (see 4 CONTRAINDICATIONS).

USE IN SPECIFIC POPULATIONS


8.1 Pregnancy

Teratogenic Effects: Pregnancy Category C:

Animal reproduction studies have not been conducted with Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension. It is not known whether this product can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension should be given to a pregnant woman only if clearly needed.


8.2 Labor and Delivery

Administration of phenylephrine in late pregnancy or labor may cause fetal anoxia or bradycardia by increasing contractility of the uterus and decreasing uterine blood flow.


8.3 Nursing Mothers

Because of the higher risk of intolerance of antihistamines in small infants generally, and in newborns and prematures in particular, Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension should not be administered to a nursing mother.

OVERDOSAGE:


10.1 Signs and Symptoms

These may vary from CNS depression to stimulation (restlessness to convulsions). Antihistamine overdosage in young children may lead to convulsions and death. Atropine-like signs and signs and symptoms may be prominent. Dextromethorphan may produce central excitement and mental confusion. Very high doses of dextromethorphan may produce respiratory depression.


10.2 Treatment

Induce vomiting if it has not occurred spontaneously. Precautions must be taken against aspiration, especially in infants, children, and comatose patients. If gastric lavage is indicated, isotonic or half-isotonic saline solution is preferred. Stimulants should not be used. If hypotension is a problem, vasopressor agents may be considered.

Pyril Mal Phenyl HCl Dex HBr Description


Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension is a grape-flavored, dye-free, combination antihistamine/nasal decongestant/antitussive suspension.

Each 5 mL (one teaspoonful) for oral administration contains:

Pyrilamine maleate......................................16 mg

Phenylephrine hydrochloride .........................5 mg

Dextromethorphan hydrobromide…………15 mg


Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension also contains: citric acid, glycerin, grape flavor, methylparaben, purified water, benzoic acid, sodium citrate, propylene glycol, propylparaben, and sodium saccharin.


Pyrilamine Maleate is an antihistamine having the chemical name, 1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N', N'-dimethyl-N-2-pyridinyl-, (Z)-2-butenedioate (1:1).


Phenylephrine hydrochloride is an orally effective nasal decongestant. Chemically it is (–)-m-Hydroxy-_- [(methylamino)methyl]benzyl alcohol hydrochloride.


Dextromethorphan hydrobromide is a salt of the methyl ether of the dextrorotatory isomer of levorphanol, a narcotic analgesic. Chemically, it is 3-methoxy-17-9_, 13_, 14_-morphinan hydrobromide monohydrate.

Pyril Mal Phenyl HCl Dex HBr - Clinical Pharmacology


Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension combines the antihistaminic action of pyrilamine with the sympathomimetic decongestant effect of phenylephrine and the antitussive effect of dextromethorphan.


12.1 Mechanism of Action

Pyrilamine maleate

Pyrilamine maleate is an antihistamine, H1 receptor blocking agent belonging to the ethylenediamine class of antihistamines. H1-blocking drugs inhibit the actions of histamine on smooth muscle, capillary permeability, and can both stimulate and depress the central nervous system. Pyrilamine also possesses anticholinergic and sedative properties.


Phenylephrine HCl

Phenylephrine hydrochloride is a decongestant which is a potent postsynaptic α-receptor agonist with little effect on β receptors of the heart. A direct action at receptors accounts for the greater part of its effects, only a small part being due to its ability to release norepinephrine. Phenylephrine has no effect on β-adrenergic receptors of the bronchi or peripheral blood vessels.


Dextromethorphan hydrobromide

Dextromethorphan is an antitussive agent and, unlike the isomeric levorphenol, it has no analgesic or addictive properties. The drug acts centrally and elevates the threshold for coughing. It is approximately equal to codeine in depressing the cough reflex. In therapeutic dosage dextromethorphan does not inhibit ciliary activity.

Nonclinical Toxicology


13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility

No long-term animal studies have been performed with Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension.

How Supplied/Storage and Handling


16.1 How Supplied

Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension is a grape-flavored, dye-free suspension supplied in 16 oz. (473 mL) bottles, NDC 68032-440-16.


16.2 Storage and Handling

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.

Store at controlled room temperature 20°-25°C (68°-77°F)


PHARMACIST: Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure.

Patient Counseling Information


Patients receiving Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension should be given the following information:

1. Do not drink alcoholic beverages or engage in potentially hazardous activities requiring alertness, such as driving a car or operating machinery, while using this drug.

2. Do not take this product if currently taking a prescription MAO inhibitor (for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAO inhibitor. Instruct patients to consult a health professional if they are unsure whether a prescription drug contains an MAO inhibitor before taking Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension.


*Sections or subsections omitted from the full prescribing information are not listed.


Manufactured for:

River’s Edge Pharmaceuticals, LLC.

Suwanee, GA 30024

Rev. 02/10 440-10

PACKAGING


NDC 68032-440-16


Pyril Mal 16mg/Phenyleph HCl 5 mg/DM HBr 15mg/5mL Suspension


Rx Only


Pyrlamine maleate 16 mg/5 mL

Phenylephrine hydrochloride 5 mg/5 mL

Dextromethorphan hydrobromide 15 mg/5 mL


Grape Flavor


EACH TEASPOONFUL (5 mL) CONTAINS:

Pyrlamine maleate .................. 16 mg

Phenylephrine HCl ..................... 5 mg

Dextromethorphan HBr ........... 15 mg


16 fl oz (473 mL)


Indications: Pyril Mal 16 mg/Phenyl HCl 5 mg/Dex HBr 15 mg/5 mL Suspension is indicated for temporary relief of the swelling and nasal congestion associated with the common cold, sinusitis, allergic rhinitis, and other upper respiratory conditions.


RECOMMENDED DOSES MAY BE ADMINISTERED EVERY 8 HOURS.

Adults and children 12 years of age and older: 5-10 mL (1-2 teaspoonfuls).

Children 6-12 years of age: 5 mL (1 teaspoonful).

Children 2-6 years of age: 2.5 mL (1/2 teaspoonful).

Under 2 years of age: Consult a physician.


See package insert for dosing information and directions for use.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY.


Store at controlled room temperature 20°-25°C (68°-77°F)

PHARMACIST: Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure.


Manufactured for:

River’s Edge Pharmaceuticals, LLC.

Suwanee, GA 30024

Rev. 02/10 440-20










Pyril Mal Phenyl HCl Dex HBr 
pyrilamine maleate, phenylephrine hydrochloride, dextromethorphan hydrobromide  suspension










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)68032-440
Route of AdministrationORALDEA Schedule    














Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRILAMINE MALEATE (PYRILAMINE)PYRILAMINE MALEATE16 mg  in 5 mL
PHENYLEPHRINE HYDROCHLORIDE (PHENYLEPHRINE)PHENYLEPHRINE HYDROCHLORIDE5 mg  in 5 mL
DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN)DEXTROMETHORPHAN HYDROBROMIDE15 mg  in 5 mL






















Inactive Ingredients
Ingredient NameStrength
CITRIC ACID MONOHYDRATE 
GLYCERIN 
METHYLPARABEN 
WATER 
SACCHARIN SODIUM 
BENZOIC ACID 
SODIUM CITRATE 
PROPYLENE GLYCOL 
PROPYLPARABEN 


















Product Characteristics
Color    Score    
ShapeSize
FlavorGRAPEImprint Code
Contains      










Packaging
#NDCPackage DescriptionMultilevel Packaging
168032-440-16473 mL In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other02/15/201002/28/2012


Labeler - River's Edge Pharmaceuticals, LLC (133879135)
Revised: 12/2010River's Edge Pharmaceuticals, LLC

More Pyril Mal Phenyl HCl Dex HBr resources


  • Pyril Mal Phenyl HCl Dex HBr Side Effects (in more detail)
  • Pyril Mal Phenyl HCl Dex HBr Dosage
  • Pyril Mal Phenyl HCl Dex HBr Use in Pregnancy & Breastfeeding
  • Pyril Mal Phenyl HCl Dex HBr Drug Interactions
  • Pyril Mal Phenyl HCl Dex HBr Support Group
  • 2 Reviews for Pyril Mal Phenyl HCl Dex HBr - Add your own review/rating


Compare Pyril Mal Phenyl HCl Dex HBr with other medications


  • Cold Symptoms
  • Hay Fever
  • Sinusitis


No comments:

Post a Comment